LiCellMo, a live cell metabolic pathway analyzer
Category: Analytical/Test
Developers: PHC Corporation
Product Description:PHCbi’s LiCellMo is a live‑cell metabolic pathway analyzer designed to change how researchers study cellular function. By directly measuring glucose and lactate levels in real time, LiCellMo enables continuous, non-disruptive monitoring of live cell metabolism, offering a view into how cells behave and respond under various conditions. By tracking these metabolic markers, scientists can gain a clearer understanding of how cells grow, respond to treatments, and adapt under stress. This continuous, non-invasive analysis could be valuable in cancer research, drug discovery and the development of cell and gene therapies. The electrochemical in-line sensors in LiCellMo use electrical changes arising from chemical reactions. The concentration of the analyte is converted into an electrical signal through enzymatic redox reactions and then quantified. The electrochemical in-line sensors used in the LiCellMo carry enzymes that bind specifically to glucose and lactate. LiCellMo could empower researchers to make more informed decisions and help accelerate the development of new therapies. It reduces the risk of misleading results that can arise from single time-point measurements, enhancing the reliability and depth of experimental outcomes. LiCellMo represents a step forward in healthcare and diagnostics by enabling scientists to observe cellular responses in a more natural, uninterrupted manner. This real-time insight can support the development of safer, more effective treatments, helps improve drug safety testing, and drives progress in personalized medicine.
Developers: PHC Corporation
Product Description:PHCbi’s LiCellMo is a live‑cell metabolic pathway analyzer designed to change how researchers study cellular function. By directly measuring glucose and lactate levels in real time, LiCellMo enables continuous, non-disruptive monitoring of live cell metabolism, offering a view into how cells behave and respond under various conditions. By tracking these metabolic markers, scientists can gain a clearer understanding of how cells grow, respond to treatments, and adapt under stress. This continuous, non-invasive analysis could be valuable in cancer research, drug discovery and the development of cell and gene therapies. The electrochemical in-line sensors in LiCellMo use electrical changes arising from chemical reactions. The concentration of the analyte is converted into an electrical signal through enzymatic redox reactions and then quantified. The electrochemical in-line sensors used in the LiCellMo carry enzymes that bind specifically to glucose and lactate. LiCellMo could empower researchers to make more informed decisions and help accelerate the development of new therapies. It reduces the risk of misleading results that can arise from single time-point measurements, enhancing the reliability and depth of experimental outcomes. LiCellMo represents a step forward in healthcare and diagnostics by enabling scientists to observe cellular responses in a more natural, uninterrupted manner. This real-time insight can support the development of safer, more effective treatments, helps improve drug safety testing, and drives progress in personalized medicine.
